Sanofi India Limited (SANOFI)
ISIN: INE058A01010 Industry: Drug Manufacturers—General Sector: Healthcare Website
6601.8
-29.1(-0.44%)

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Pricing Updates

TODAY'S HIGH

6675

TODAY'S LOW

6568.2

52 WEEK HIGH

9285

52 WEEK LOW

6351

Major Holders

% of Shares Held by
All Insider

60.55%

% of Shares Held by
Institutions

25.31%

% of Float Held by
Institutions

64.16%

Number of Institutions
Holding Shares

54

Company Overview

MARKET CAP

15211.99 Cr.

ETERPRISE VALUE

13757.97 Cr.

NO. OF SHARES

2.30 Cr.

BOOK VALUE

966.366

DIV. YIELD

309%

DEBT

24.60 Cr.

GROSS PROFIT

1633.10 Cr.

CASH

1537.99 Cr.

REVENUE

2938.50 Cr.

REVENUE/SHARE

1275.899

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsDec 2021Dec 2020Dec 2019Dec 2018
Investments0000
Change To Liabilities67.10 Cr.-1.80 Cr.23.30 Cr.12.50 Cr.
Total cashflows from Investing Activities630.80 Cr.276.40 Cr.65.70 Cr.-73.10 Cr.
Net Borrowings-6.60 Cr.-4.60 Cr.-4.60 Cr.-4.60 Cr.
Total Cash from Financing Activities-849 Cr.-810 Cr.-183.20 Cr.-197.20 Cr.
Other Liabilities33.40 Cr.81 Cr.-9.70 Cr.-13.30 Cr.
Total Assets0000
Net Income944.40 Cr.477.60 Cr.414.20 Cr.380.60 Cr.
Change in Cash340.60 Cr.77.50 Cr.294.80 Cr.103.60 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities558.80 Cr.611.10 Cr.412.30 Cr.373.90 Cr.
Depreciation65.30 Cr.81 Cr.98.30 Cr.100.80 Cr.
Other Cashflows from Investing Activities63.10 Cr.78 Cr.91 Cr.78.90 Cr.
Dividends Paid-287.87 Cr.-244.13 Cr.-152 Cr.-163.60 Cr.
Change to Inventory-33.60 Cr.-22.20 Cr.13.50 Cr.-67.50 Cr.
Change to Account Receivables1.20 Cr.5.20 Cr.-64.80 Cr.40.70 Cr.
Other Cashflows from Financing Activities-1.80 Cr.-1.60 Cr.-31.20 Cr.-33.60 Cr.
Change to Net Income-520.40 Cr.-10.90 Cr.-64.10 Cr.-81.80 Cr.
Capital Expenditures-23 Cr.-41.40 Cr.-75.80 Cr.-59.20 Cr.

Financials

ParticularsDec 2021Dec 2020Dec 2019Dec 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax1257.60 Cr.677.20 Cr.599.90 Cr.609.80 Cr.
Minority InterestNoneNoneNoneNone
Net Income695.90 Cr.633.80 Cr.567.60 Cr.522.70 Cr.
Selling General Administrative483.70 Cr.516.40 Cr.544.60 Cr.492.80 Cr.
Gross Profit1633.10 Cr.1622.90 Cr.1691.90 Cr.1598.60 Cr.
Ebit695.90 Cr.633.80 Cr.567.60 Cr.522.70 Cr.
Operating Income695.90 Cr.633.80 Cr.567.60 Cr.522.70 Cr.
Other Operating Expenses386.80 Cr.390.50 Cr.479.80 Cr.480.40 Cr.
Interest Expense-1.80 Cr.-1.80 Cr.-30 Lakhs-70 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense313.20 Cr.199.60 Cr.185.70 Cr.229.20 Cr.
Total Revenue2956.60 Cr.2901.90 Cr.3070.60 Cr.2770.80 Cr.
Total Operating Expenses2260.70 Cr.2268.10 Cr.2503 Cr.2248.10 Cr.
Cost of Revenue1323.50 Cr.1279 Cr.1378.70 Cr.1172.20 Cr.
Total Other Income Expense Net561.70 Cr.43.40 Cr.32.30 Cr.87.10 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.944.40 Cr.477.60 Cr.414.20 Cr.380.60 Cr.
Net Income Applicable to Common Shares944.40 Cr.477.60 Cr.414.20 Cr.380.60 Cr.

Balance Sheet

ParticularsDec 2021Dec 2020Dec 2019Dec 2018
Intangible Assets5.20 Cr.38.10 Cr.77.60 Cr.116.50 Cr.
Capital Surplus2 Cr.2 Cr.2 Cr.2 Cr.
Total Liabilities835.40 Cr.799.50 Cr.802.10 Cr.764.70 Cr.
Stock Holder Equity2225.60 Cr.2119 Cr.2442.30 Cr.2219.20 Cr.
Minority Interest0000
Other Liabilities214.60 Cr.222.30 Cr.194.80 Cr.173.20 Cr.
Total Assets3061 Cr.2918.50 Cr.3244.40 Cr.2983.90 Cr.
Common Stock23 Cr.23 Cr.23 Cr.23 Cr.
Retained Earnings2140.50 Cr.2040 Cr.2375 Cr.2160.50 Cr.
Other Liabilities68.20 Cr.94.80 Cr.98.70 Cr.141.20 Cr.
Good Will073.10 Cr.73.10 Cr.73.10 Cr.
Treasury Stock60.10 Cr.54 Cr.42.30 Cr.33.70 Cr.
Other Assets576.20 Cr.611.10 Cr.599 Cr.637.60 Cr.
Cash1538 Cr.1197.40 Cr.1119.90 Cr.825.10 Cr.
Current Liabilities749.60 Cr.686.80 Cr.703.40 Cr.623.50 Cr.
Long Term Asset Charges0000
Short Long Term Debt0000
Other Stockholder Equity60.10 Cr.54 Cr.42.30 Cr.33.70 Cr.
Property Plant Equipment341.70 Cr.362.90 Cr.365.40 Cr.564.30 Cr.
Total Cur. Assets2137.90 Cr.1833.30 Cr.2129.30 Cr.1592.20 Cr.
Long Term Investments00020 Lakhs
Net Tangible Assets2220.40 Cr.2007.80 Cr.2291.60 Cr.2029.60 Cr.
Short Term Investments0000
Net Receivables153.80 Cr.192.50 Cr.260.40 Cr.190.10 Cr.
Long Term Debt0000
Inventory392.40 Cr.368 Cr.469.60 Cr.491.60 Cr.
Accounts Payable376.70 Cr.318.30 Cr.368.90 Cr.343.80 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account